Mostrar o rexistro simple do ítem

dc.contributor.authorCano, A.
dc.contributor.authorAlcalde, C.
dc.contributor.authorBelanger-Quintana, A.
dc.contributor.authorCañedo-Villarroya, E.
dc.contributor.authorCeberio, L.
dc.contributor.authorChumillas-Calzada, S.
dc.contributor.authorCorrecher, P.
dc.contributor.authorCouce Pico, María Luz
dc.contributor.authorGarcía-Arenas, D.
dc.contributor.authorGómez, I.
dc.contributor.authorHernández, T.
dc.contributor.authorIzquierdo-García, E.
dc.contributor.authorChicano, D.M.
dc.contributor.authorMorales, M.
dc.contributor.authorPedrón-Giner, C.
dc.contributor.authorJáuregui, E.P.
dc.contributor.authorPeña-Quintana, L.
dc.contributor.authorSánchez Pintos, Paula 
dc.contributor.authorSerrano-Nieto, J.
dc.contributor.authorSuarez, M.U.
dc.contributor.authorMiñana, I.V.
dc.contributor.authorde las Heras, J.
dc.date.accessioned2025-08-26T08:50:15Z
dc.date.available2025-08-26T08:50:15Z
dc.date.issued2022
dc.identifier.citationCano A, Alcalde C, Belanger-Quintana A, Cañedo-Villarroya E, Ceberio L, Chumillas-Calzada S, et al. Vitamin C and folate status in hereditary fructose intolerance. European Journal of Clinical Nutrition. 2022;76(12):1733-9.
dc.identifier.issn1476-5640
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/62e5c2ede5f0e01a6a1d02fd*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20624
dc.description.abstractBackground: Hereditary fructose intolerance (HFI) is a rare inborn error of fructose metabolism caused by the deficiency of aldolase B. Since treatment consists of a fructose-, sucrose- and sorbitol-restrictive diet for life, patients are at risk of presenting vitamin deficiencies. Although there is no published data on the status of these vitamins in HFI patients, supplementation with vitamin C and folic acid is common. Therefore, the aim of this study was to assess vitamin C and folate status and supplementation practices in a nationwide cohort of HFI patients. Methods: Vitamin C and folic acid dietary intake, supplementation and circulating levels were assessed in 32 HFI patients and 32 age- and sex-matched healthy controls. Results: Most of the HFI participants presented vitamin C (96.7%) and folate (90%) dietary intake below the recommended population reference intake. Up to 69% received vitamin C and 50% folic acid supplementation. Among HFI patients, 15.6% presented vitamin C and 3.1% folate deficiency. The amount of vitamin C supplementation and plasma levels correlated positively (R = 0.443; p = 0.011). Interestingly, a higher percentage of non-supplemented HFI patients were vitamin C deficient when compared to supplemented HFI patients (30% vs. 9.1%; p = 0.01) and to healthy controls (30% vs. 3.1%; p < 0.001). Conclusions: Our results provide evidence for the first time supporting vitamin C supplementation in HFI. There is great heterogeneity in vitamin supplementation practices and, despite follow-up at specialised centres, vitamin C deficiency is common. Further research is warranted to establish optimal doses of vitamin C and the need for folic acid supplementation in HFI.en
dc.description.sponsorshipThis work was supported by Exp. No. 2018111095, Basque Government, Health Department; FEDER, the Spanish Federation for Rare Diseases (FI18053); and DanoneNutricia-Metabolics, which was not involved in the study hypothesis/design, execution, analysis, or interpretation.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleVitamin C and folate status in hereditary fructose intolerance*
dc.typeArticleen
dc.authorsophosCano, J. A.
dc.authorsophosAlcalde, C.
dc.authorsophosBelanger-Quintana, A.
dc.authorsophosCañedo-Villarroya, E.
dc.authorsophosCeberio, L.
dc.authorsophosChumillas-Calzada, S.
dc.authorsophosCorrecher, P.
dc.authorsophosCouce, M. L.
dc.authorsophosGarcía-Arenas, D.
dc.authorsophosGómez, I.
dc.authorsophosHernández, T.
dc.authorsophosIzquierdo-García, E.
dc.authorsophosChicano, D. M.
dc.authorsophosMorales, M.
dc.authorsophosPedrón-Giner, C.
dc.authorsophosJáuregui, E. P.
dc.authorsophosPeña-Quintana, L.
dc.authorsophosSánchez-Pintos, P.
dc.authorsophosSerrano-Nieto, J.
dc.authorsophosSuarez, M. U.
dc.authorsophosMiñana, I. V.
dc.authorsophosde las, Heras
dc.identifier.doi10.1038/s41430-022-01178-3
dc.identifier.sophos62e5c2ede5f0e01a6a1d02fd
dc.issue.number12
dc.journal.titleEuropean Journal of Clinical Nutrition*
dc.page.initial1733
dc.page.final1739
dc.relation.projectIDBasque Government, Health Department [2018111095]; FEDER, the Spanish Federation for Rare Diseases [FI18053]
dc.relation.publisherversionhttps://www.nature.com/articles/s41430-022-01178-3.pdfes
dc.rights.accessRightsopenAccess
dc.subject.keywordAS Santiagoes
dc.subject.keywordCHUSes
dc.subject.keywordIDISes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo Originales
dc.volume.number76


Ficheiros no ítem

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem

Atribución 4.0 Internacional
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAtribución 4.0 Internacional